Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
about
The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesisN-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.Immortalization of mouse neural precursor cells by the c-myc oncogeneTransgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.Control of B cell development by Ras-mediated activation of Raf.Expression of chicken liver cell adhesion molecule fusion genes in transgenic mice.Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatallyAnimal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes.MYC levels govern hematopoietic tumor type and latency in transgenic miceExpression of functional c-kit receptors rescues the genetic defect of W mutant mast cellsPathology of spontaneous and oncogene transformed rat liver epithelial cells and derived tumours in nude mice.The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cellsRelationship of variable region genes expressed by a human B cell lymphoma secreting pathologic anti-Pr2 erythrocyte autoantibodies.Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl.A bcr-v-abl oncogene induces lymphomas in transgenic mice.A viral long terminal repeat expressed in CD4+CD8+ precursors is downregulated in mature peripheral CD4-CD8+ or CD4+CD8- T cells.An overview of tumor biology.Cancer genes by illegitimate recombination.Expression of the rat myosin light-chain 2 gene in transgenic mice: stage specificity, developmental regulation, and interrelation with the endogenous gene.Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice.Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.Abelson murine leukemia virus transforms preneoplastic Emu-myc transgene-carrying cells of the B-lymphocyte lineage into plasmablastic tumors.
P2860
Q24519077-7C661448-B63C-4E6F-9672-65996BA2D233Q33561040-E0314A95-E79D-4DEE-9F8E-DE9148AF82C0Q33572128-CC639E07-44F4-4DC6-A229-12B760726829Q33640664-9197F970-4EB4-495B-957D-9721A13FE6C0Q33887809-C532350B-19A8-48FD-A036-D7719F21A2B3Q33902998-667D6FFE-FC5E-4599-AAEF-19B751FC5964Q34613693-8F6F519B-DE79-444A-AF1A-3D6A038BC4ACQ35817599-323328CE-8051-4F71-89E3-12C1DC0F80E3Q35848951-840A25CD-B453-4953-B4A6-82498ABB2162Q35934945-1E204EFA-2992-46CB-8844-A40228F2DCFAQ36029662-B9DB246C-C3F3-4E07-B3F4-0D6C1B1638E8Q36354457-31367C65-C124-4F45-BECD-93F98FD37464Q36356325-46E03831-B6F1-4748-B7BD-1661EB5C2632Q36752903-F96EDBEB-CFB8-472D-B5C1-16F0E23C0F46Q36769035-BB0CD42F-0F5F-4D36-8700-80E1B1EE96BAQ36821516-03DD6118-2DFF-4EB7-89AC-A005D0716F3CQ38234846-0EE6C888-322E-4657-8806-CE3885E04F41Q38705301-D34D4A72-A9BC-467F-AD56-AA9B9B11B11FQ40649072-F933FCF1-2507-4AE6-98A7-AC9359D439C8Q41671471-4313AEDA-6395-4799-B4D5-A4F75F749B08Q42939811-ACFEA8BA-A9C0-48F1-84C3-8D347AB0F32BQ45850077-60043831-D9F3-40E5-909E-B1D0F35390F3
P2860
Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Expression of the c-myc oncoge ...... r in E mu-myc transgenic mice.
@en
type
label
Expression of the c-myc oncoge ...... r in E mu-myc transgenic mice.
@en
prefLabel
Expression of the c-myc oncoge ...... r in E mu-myc transgenic mice.
@en
P2093
P2860
P356
P1476
Expression of the c-myc oncoge ...... r in E mu-myc transgenic mice.
@en
P2093
J W Schrader
W S Alexander
P2860
P304
P356
10.1128/MCB.7.4.1436
P407
P577
1987-04-01T00:00:00Z